Form D · Biotechnology
ALDEA Pharmaceuticals, Inc.
Redwood City, CA · CIK 0001531984
Offering snapshot reported Aug 25, 2014 · SEC filing
- Reported sold
- $9.26M Offering amount: $24.1M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 11, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 25, 2014 | Initial | $9,262,658 | No comparison | 5 | SEC filing |
| Nov 18, 2013 | Amendment | $11,380,718 | $6,867,227vs May 8, 2012 | 6 | SEC filing |
| May 8, 2012 | Amendment | $4,513,491 | $3,236,491vs Feb 15, 2012 | 6 | SEC filing |
| Feb 15, 2012 | Amendment | $1,277,000 | $250,000vs Oct 6, 2011 | 5 | SEC filing |
| Oct 6, 2011 | Initial | $1,027,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-223549
Offering of convertible promissory notes ("Notes"), Series B Preferred Stock ("Series B"), the underlying shares of Series B issuable upon conversion of Notes and the underlying shares of Common Stock issuable upon conversion of Series B.
Source: Form D, filed Aug 25, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Wende Hutton | Director |
| Vernon Jiang, Ph.D. | Executive |
| Daria Mochly Rosen | Director |
| Howard Rosen | Director |
| Richard Shames, M.D. | Executive |
| Timothy Shannon | Director |
| John Walker | Director |
| Wenjin Yang | Executive |
| William Yelle | Director, Executive |
| Evgeny Zaytsev | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3696 Haven Ave., Suite C
Redwood City, CA, 94063
Redwood City, CA, 94063